Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F13640 proof-of-concept study in opioid-refractory cancer pain
2007-003249-34Phase 2Terminated
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer pain comparing F13640 plus opioid therapy with Placebo plus opioid therapy (2 arms). Primary endpoint: Responder rate based on pain intensity VAS. Started Jul 2007; status: terminated.
02
Drugs
NLX-112
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2007-003249-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003249-34.